- A novel modality of BAFF-specific inhibitor AMG623 peptibody reduces B-cell number and improves outcomes in murine models of autoimmune disease. Hsu, H., Khare, S.D., Lee, F., Miner, K., Hu, Y.L., Stolina, M., Hawkins, N., Chen, Q., Ho, S.Y., Min, H., Xiong, F., Boone, T., Zack, D.J. Clin. Exp. Rheumatol. (2012)